'Breakthrough' CRISPR Treatment Slashes Cholesterol in First Human Clinical Trial
A single gene-editing infusion slashed artery-clogging fat by up to 55 percent. If all goes well, the one-shot treatment could last a lifetime.
Stay updated with breaking news from Gerald Schwank. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A single gene-editing infusion slashed artery-clogging fat by up to 55 percent. If all goes well, the one-shot treatment could last a lifetime.
Using a CRISPR-guided technique called "base editing," scientists edited the genes of liver cells in 10 people's bodies.
Genome editing technologies provide huge opportunities for the treatment of genetic diseases. Procedures such as the extensively used CRISPR/Cas9 gene scissors directly deal with the reason for the disease in the DNA.
Scientists know the DNA letter swap that can, in theory, drastically lower LDL-C and in turn throttle the risk of heart attacks.
Three researchers at the University of Zurich have been awarded much coveted ERC Consolidator Grants by the EU. They were recognized for their project....